StockStory.org on MSN5d
Organon (NYSE:OGN) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations Significantly
Pharmaceutical company Organon (NYSE:OGN) reported Q4 CY2024 results , but sales were flat year on year at $1.59 billion. On ...
Earnings call transcript: Arca Continental reports robust Q4 2024 growth
Arca Continental, one of the leading beverage companies in Latin America, reported significant growth in its Q4 2024 financial results. The company's consolidated revenues increased by 29.9% to MXN 64 ...